Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling

Pflugers Archiv European Journal of Physiology

Volumn 466, Issue 6, 2014, Pages 1113-1127

  Ma, Yonggang ^a,b   De Castro Brás, Lisandra E ^a,b   Toba, Hiroe ^a,b,f   Iyer, Rugmani Padmanabhan ^a,b   Hall, Michael E ^a,b   Winniford, Michael D ^a,b   Lange, Richard A ^a,c   Tyagi, Suresh C ^d   Lindsey, Merry L ^a,b,e  

^a San Antonio Cardiovascular Proteomics Center   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d University of Louisville School of Medicine   (United States)

^e G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Extracellular matrix; MMP 9; Myocardial infarction; Myofibroblast; Proteomics; Review

Indexed keywords

COLLAGEN; FIBRONECTIN; GALECTIN 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LAMININ; MATRICRYPTIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 28; NEUTROPHIL COLLAGENASE; PROTEOGLYCAN; SCLEROPROTEIN; SMALL LEUCINE RICH PROTEOGLYCAN; STROMELYSIN; SYNDECAN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG; VITRONECTIN;

CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; EXTRACELLULAR MATRIX; FIBROBLAST; HEART INFARCTION; HEART REMODELING; HUMAN; MYOFIBROBLAST; PRIORITY JOURNAL; REGENERATION; REVIEW; ANIMAL; GENETICS; HEART VENTRICLE REMODELING; METABOLISM; PATHOLOGY;

ANIMALS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MYOCARDIAL INFARCTION; MYOFIBROBLASTS; VENTRICULAR REMODELING;

EID: 84901933884     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-014-1463-9     Document Type: Review

References (136)

1. Adair-Kirk TL, Atkinson JJ, Kelley DG, Arch RH, Miner JH, Senior RM (2005) A chemotactic peptide from laminin alpha 5 functions as a regulator of inflammatory immune responses via TNF alpha-mediated signaling. J Immunol 174(3):1621-1629
2. Arslan F, Smeets MB, Riem Vis PW, Karper JC, Quax PH, Bongartz LG, Peters JH, Hoefer IE, Doevendans PA, Pasterkamp G, de Kleijn DP (2011) Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction. Circ Res 108(5):582-592. doi:10.1161/CIRCRESAHA.110.224428
3. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107(12):1579-1585. doi:10.1161/01.CIR.0000058700.41738.12 (Pubitemid 36397324)
4. Bornstein P (2009) Matricellular proteins: an overview. J Cell Commun Signal 3(3-4):163-165. doi:10.1007/s12079-009-0069-z
5. Brown RD, Ambler SK, Mitchell MD, Long CS (2005) The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45:657-687. doi:10.1146/annurev.pharmtox.45.120403.095802 (Pubitemid 40261821)
6. Bujak M, Frangogiannis NG (2007) The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74(2):184-195. doi:10.1016/j.cardiores.2006.10.002 (Pubitemid 46517504)
7. Burstein B, Libby E, Calderone A, Nattel S (2008) Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 117(13):1630-1641. doi:10.1161/CIRCULATIONAHA.107.748053 (Pubitemid 351482606)
8. Camelliti P, Borg TK, Kohl P (2005) Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 65(1):40-51. doi:10.1016/j.cardiores.2004.08.020 (Pubitemid 40038477)
9. Camp TM, Tyagi SC, Aru GM, Hayden MR, Mehta JL (2004) Doxycycline ameliorates ischemic and border-zone remodeling and endothelial dysfunction after myocardial infarction in rats. J Heart Lung Transplant 23(6):729-736 (Pubitemid 38721443)
10. Caplan AI, Dennis JE (2006) Mesenchymal stem cells as trophic mediators. J Cell Biochem 98(5):1076-1084. doi:10.1002/jcb.20886 (Pubitemid 44128350)
11. Carey DJ (1997) Syndecans: multifunctional cell-surface coreceptors. Biochem J 327(Pt 1):1-16
12. Carver W, Terracio L, Borg TK (1993) Expression and accumulation of interstitial collagen in the neonatal rat heart. Anat Rec 236(3):511-520. doi:10.1002/ar.1092360311 (Pubitemid 23193319)
13. Chang C, Werb Z (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11(11):S37-S43
14. Chen S, Birk DE (2013) The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly. Febs J 280(10):2120-2137. doi:10.1111/febs.12136
15. Chiao YA, Zamilpa R, Lopez EF, Dai Q, Escobar GP, Hakala K, Weintraub ST, Lindsey ML (2010) In vivo matrix metalloproteinase-7 substrates identified in the left ventricle postmyocardial infarction using proteomics. J Proteome Res 9(5):2649-2657. doi:10.1021/pr100147r
16. Cicoira M, Rossi A, Bonapace S, Zanolla L, Golia G, Franceschini L, Caruso B, Marino PN, Zardini P (2004) Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. J Card Fail 10(5):403-411 (Pubitemid 41080221)
17. Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT (1995) Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27(6):1281-1292
18. Coker ML, Jolly JR, Joffs C, Etoh T, Holder JR, Bond BR, Spinale FG (2001) Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation. Am J Physiol Heart Circ Physiol 281(2):H543-H551
19. Daniels A, van Bilsen M, Goldschmeding R, van der Vusse GJ, van Nieuwenhoven FA (2009) Connective tissue growth factor and cardiac fibrosis. Acta Physiol (Oxf) 195(3):321-338. doi:10.1111/j.1748-1716.2008.01936.x
20. de Castro Bras LE, Ramirez TA, DeLeon-Pennell KY, Chiao YA, Ma Y, Dai Q, Halade GV, Hakala K, Weintraub ST, Lindsey ML (2013) Texas 3-step decellularization protocol: looking at the cardiac extracellular matrix. J Proteomics 86:43-52. doi:10.1016/j.jprot.2013.05.004
21. Derer W, Barnathan ES, Safak E, Agarwal P, Heidecke H, Mockel M, Gross M, Oezcelik C, Dietz R, Dechend R (2009) Vitronectin concentrations predict risk in patients undergoing coronary stenting. Circ Cardiovasc Interv 2(1):14-19. doi:10.1161/CIRCINTERVENTIONS.108.795799
22. Dinh W, Bansemir L, Futh R, Nickl W, Stasch JP, Coll-Barroso M, Lapp H, Bufe A, Wolfertz J, Scheffold T, Lankisch M (2009) Increased levels of laminin and collagen type VI may reflect early remodelling in patients with acute myocardial infarction. Acta Cardiol 64(3):329-334
23. Douglas T, Heinemann S, Bierbaum S, Scharnweber D, Worch H (2006) Fibrillogenesis of collagen types I, II, and III with small leucine-rich proteoglycans decorin and biglycan. Biomacromolecules 7(8):2388-2393. doi:10.1021/bm0603746 (Pubitemid 44336350)
24. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106(1):55-62. doi:10.1172/JCI8768 (Pubitemid 30437240)
25. Dumic J, Dabelic S, Flogel M (2006) Galectin-3: an open-ended story. Biochim Biophys Acta 1760(4):616-635. doi:10.1016/j.bbagen.2005.12.020 (Pubitemid 44382499)
26. Ekmekci H, Sonmez H, Ekmekci OB, Ozturk Z, Domanic N, Kokoglu E (2002) Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of disease. J Thromb Thrombolysis 14(3):221-225 (Pubitemid 37069305)
27. Faisal Khan KM, Laurie GW, McCaffrey TA, Falcone DJ (2002) Exposure of cryptic domains in the alpha 1-chain of laminin-1 by elastase stimulates macrophages urokinase and matrix metalloproteinase-9 expression. J Biol Chem 277(16):13778-13786. doi:10.1074/jbc.M111290200 (Pubitemid 34967981)
28. Fligny C, Duffield JS (2013) Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction. Curr Opin Rheumatol 25(1):78-86. doi:10.1097/BOR.0b013e32835b656b
29. Frangogiannis NG (2012) Matricellular proteins in cardiac adaptation and disease. Physiol Rev 92(2):635-688. doi:10.1152/physrev.00008.2011
30. Frey H, Schroeder N, Manon-Jensen T, Iozzo RV, Schaefer L (2013) Biological interplay between proteoglycans and their innate immune receptors in inflammation. Febs J 280(10):2165-2179. doi:10.1111/febs.12145
31. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, Ruadkow IA (1974) Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2(2):83-92
32. Fukuda T, Yoshida N, Kataoka Y, Manabe R, Mizuno-Horikawa Y, Sato M, Kuriyama K, Yasui N, Sekiguchi K (2002) Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro. Cancer Res 62(19):5603-5610
33. Gittenberger-de Groot AC, Vrancken Peeters MP, Mentink MM, Gourdie RG, Poelmann RE (1998) Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ Res 82(10):1043-1052 (Pubitemid 28253329)
34. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB (2013) Heart Disease and Stroke Statistics-2014 Update: A Report From the American Heart Association. Circulation. doi:10.1161/01.cir. 0000441139.02102.80
35. Gondokaryono SP, Ushio H, Niyonsaba F, Hara M, Takenaka H, Jayawardana ST, Ikeda S, Okumura K, Ogawa H (2007) The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukoc Biol 82(3):657-665. doi:10.1189/jlb.1206730 (Pubitemid 47367158)
36. Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A, Kalluri R (2003) Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3(6):589-601 (Pubitemid 36808653)
37. Hammoud L, Lu X, Lei M, Feng Q (2011) Deficiency in TIMP-3 increases cardiac rupture and mortality post-myocardial infarction via EGFR signaling: beneficial effects of cetuximab. Basic Res Cardiol 106(3):459-471. doi:10.1007/s00395-010-0147-7
38. Hinz B (2006) Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur J Cell Biol 85(3-4):175-181. doi:10.1016/j.ejcb.2005.09.004
39. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C (2001) Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12(9):2730-2741 (Pubitemid 33051938)
40. Hinz B, Gabbiani G, Chaponnier C (2002) The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J Cell Biol 157(4):657-663. doi:10.1083/jcb.200201049 (Pubitemid 34839793)
41. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G (2007) Themyofibroblast: one function, multiple origins. Am J Pathol 170(6):1807-1816. doi:10.2353/ajpath.2007.070112 (Pubitemid 47339255)
42. Hinz B, Pittet P, Smith-Clerc J, Chaponnier C, Meister JJ (2004) Myofibroblast development is characterized by specific cell-cell adherens junctions. Mol Biol Cell 15(9):4310-4320. doi:10.1091/mbc.E04-05-0386 (Pubitemid 39122032)
43. Ignotz RA, Massague J (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261(9):4337-4345 (Pubitemid 17198877)
44. Ikonomidis JS, Hendrick JW, Parkhurst AM, Herron AR, Escobar PG, Dowdy KB, Stroud RE, Hapke E, Zile MR, Spinale FG (2005) Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition. Am J Physiol Heart Circ Physiol 288(1):H149-H158. doi:10.1152/ajpheart.00370.2004 (Pubitemid 40023842)
45. Isobe K, Kuba K, Maejima Y, Suzuki J, Kubota S, Isobe M (2010) Inhibition of endostatin/collagen XVIII deteriorates left ventricular remodeling and heart failure in rat myocardial infarction model. Circ J 74(1):109-119
46. Iyer RP, Patterson NL, Fields GB, Lindsey ML (2012) The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am J Physiol Heart Circ Physiol 303(8):H919-H930. doi:10.1152/ajpheart.00577.2012
47. Joyner AL, Zervas M (2006) Genetic inducible fate mapping in mouse: establishing genetic lineages and defining genetic neuroanatomy in the nervous system. Dev Dyn 235(9):2376-2385. doi:10.1002/dvdy.20884 (Pubitemid 44325253)
48. Kandalam V, Basu R, Abraham T, Wang X, Awad A, Wang W, Lopaschuk GD, Maeda N, Oudit GY, Kassiri Z (2010) Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction. Am J Physiol Heart Circ Physiol 299(4):H1012-H1023. doi:10.1152/ajpheart.00246.2010
49. Kandalam V, Basu R, Abraham T, Wang X, Soloway PD, Jaworski DM, Oudit GY, Kassiri Z (2010) TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation. Circ Res 106(4):796-808. doi:10.1161/CIRCRESAHA.109.209189
50. Keene DR, San Antonio JD, Mayne R, McQuillan DJ, Sarris G, Santoro SA, Iozzo RV (2000) Decorin binds near the C terminus of type I collagen. J Biol Chem 275(29):21801-21804. doi:10.1074/jbc.C000278200 (Pubitemid 30621746)
51. Kelly D, Khan S, Cockerill G, Ng LL, Thompson M, Samani NJ, Squire IB (2008) Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction. Eur J Heart Fail 10(2):133-139. doi:10.1016/j.ejheart.2007.12.009
52. Kojima T, Takagi A, Maeda M, Segawa T, Shimizu A, Yamamoto K, Matsushita T, Saito H (2001) Plasma levels of syndecan-4 (ryudocan) are elevated in patients with acute myocardial infarction. Thromb Haemost 85(5):793-799 (Pubitemid 32421810)
53. Koskivirta I, Kassiri Z, Rahkonen O, Kiviranta R, Oudit GY, McKee TD, Kyto V, Saraste A, Jokinen E, Liu PP, Vuorio E, Khokha R (2010) Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload. J Biol Chem 285(32):24487-24493. doi:10.1074/jbc.M110.136820
54. Kovacic JC, Mercader N, Torres M, Boehm M, Fuster V (2012) Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease. Circulation 125(14):1795 - 1808. doi:10.1161/CIRCULATIONAHA.111.040352
55. Lajiness JD, Conway SJ (2013) Origin, development, and differentiation of cardiac fibroblasts. J Mol Cell Cardiol. doi:10.1016/j.yjmcc.2013.11.003
56. Lei J, Xue SN, Wu W, Zhou SX, Zhang YL, Yuan GY, Wang JF (2012) Increased level of soluble syndecan-1 in serum correlates with myocardial expression in a rat model of myocardial infarction. Mol Cell Biochem 359(1-2):177-182. doi:10.1007/s11010-011-1012-1
57. Li J, Brown LF, Laham RJ, Volk R, Simons M (1997) Macrophage-dependent regulation of syndecan gene expression. Circ Res 81(5):785-796 (Pubitemid 27467213)
58. Liao YF, Gotwals PJ, Koteliansky VE, Sheppard D, Van De Water L (2002) The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem 277(17):14467- 14474. doi:10.1074/jbc. M201100200
59. Lin M, Jackson P, Tester AM, Diaconu E, Overall CM, Blalock JE, Pearlman E (2008) Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro. Am J Pathol 173(1):144-153. doi:10.2353/ajpath.2008.080081 (Pubitemid 351947962)
60. Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, Mains IM, Hendrick JK, Hewett KW, Gourdie RG, Matrisian LM, Spinale FG (2006) Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation 113(25):2919-2928. doi:10.1161/CIRCULATIONAHA.106.612960 (Pubitemid 44297233)
61. Lindsey ML, Goshorn DK, Squires CE, Escobar GP, Hendrick JW, Mingoia JT, Sweterlitsch SE, Spinale FG (2005) Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc Res 66(2):410-419. doi:10.1016/j.cardiores.2004.11.029 (Pubitemid 40471056)
62. Lindsey ML, Yoshioka J, MacGillivray C, Muangman S, Gannon J, Verghese A, Aikawa M, Libby P, Krane SM, Lee RT (2003) Effect of a cleavage-resistant collagen mutation on left ventricular remodeling. Circ Res 93(3):238-245. doi:10.1161/01.RES.0000085580.45279.60 (Pubitemid 36993235)
63. Lindsey ML, Zamilpa R (2012) Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc Ther 30(1):31-41. doi:10.1111/j.1755-5922. 2010.00207.x
64. Lu L, Zhang JQ, Ramires FJ, Sun Y (2004) Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue. Biochem Biophys Res Commun 320(3):907-913. doi:10.1016/j.bbrc.2004.06.034 (Pubitemid 38887229)
65. Luria EA, Panasyuk AF, Friedenstein AY (1971) Fibroblast colony formation from monolayer cultures of blood cells. Transfusion 11(6):345-349
66. Luther DJ, Thodeti CK, Shamhart PE, Adapala RK, Hodnichak C, Weihrauch D, Bonaldo P, Chilian WM, Meszaros JG (2012) Absence of type VI collagen paradoxically improves cardiac function, structure, and remodeling after myocardial infarction. Circ Res 110(6):851-856. doi:10.1161/CIRCRESAHA.111. 252734
67. Ma Y, Chiao YA, Zhang J, Manicone AM, Jin YF, Lindsey ML (2012) Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging. Microsc Microanal 18(1):81-90. doi:10.1017/ S1431927611012220
68. Ma Y, Halade GV, Lindsey ML (2012) Extracellular matrix and fibroblast communication following myocardial infarction. J Cardiovasc Transl Res 5(6):848 -857. doi:10.1007/s12265-012-9398-z
69. Ma Y, Halade GV, Zhang J, Ramirez TA, Levin D, Voorhees A, Jin YF, Han HC, Manicone AM, Lindsey ML (2013) Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation. Circ Res 112(4):675-688. doi:10.1161/CIRCRESAHA.111.300502
70. Ma Y, Yabluchanskiy A, Lindsey ML (2013) Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair 6(1):11. doi:10.1186/1755-1536-6-11
71. Ma Y, Yabluchanskiy A, Lindsey ML (2013) Thrombospondin-1: the good, the bad, and the complicated. Circ Res 113(12):1272-1274. doi:10.1161/CIRCRESAHA. 113.302749
72. Madsen CD, Sidenius N (2008) The interaction between urokinase receptor and vitronectin in cell adhesion and signalling. Eur J Cell Biol 87(8-9):617-629. doi:10.1016/j.ejcb.2008.02.003
73. Manicone AM, Birkland TP, Lin M, Betsuyaku T, van Rooijen N, Lohi J, Keski-Oja J, Wang Y, Skerrett SJ, Parks WC (2009) Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia. J Immunol 182(6):3866-3876. doi:10.4049/jimmunol.0713949
74. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A, Donnelly SC, McDonald K (2007) Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115(7):888-895. doi:10.1161/CIRCULATIONAHA.106.638569 (Pubitemid 46294729)
75. Matsui Y, Ikesue M, Danzaki K, Morimoto J, Sato M, Tanaka S, Kojima T, Tsutsui H, Uede T (2011) Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. Circ Res 108(11):1328-1339. doi:10.1161/CIRCRESAHA. 110.235689
76. Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, Okada Y (2005) Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest 115(3):599-609. doi:10.1172/JCI22304 (Pubitemid 40322234)
77. May AE, Schmidt R, Kanse SM, Chavakis T, Stephens RW, Schomig A, Preissner KT, Neumann FJ (2002) Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction. Blood 100(10):3611-3617. doi:10.1182/blood-2002-03-0778 (Pubitemid 35303930)
78. Mayr A, Klug G, Mair J, Streil K, Harrasser B, Feistritzer HJ, Jaschke W, Schocke M, Pachinger O, Metzler B (2013) Galectin-3: relation to infarct scar and left ventricular function after myocardial infarction. Int J Cardiol 163(3):335-337. doi:10.1016/j.ijcard.2012.06.087
79. McCurdy SM, Dai Q, Zhang J, Zamilpa R, Ramirez TA, Dayah T, Nguyen N, Jin YF, Bradshaw AD, Lindsey ML (2011) SPARC mediates early extracellular matrix remodeling following myocardial infarction. Am J Physiol Heart Circ Physiol 301(2):H497-H505. doi:10.1152/ajpheart.01070.2010
80. Melchior-Becker A, Dai G, Ding Z, Schafer L, Schrader J, Young MF, Fischer JW (2011) Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype. J Biol Chem 286(19):17365-17375. doi:10.1074/jbc.M110.192682
81. Monboisse JC, Garnotel R, Bellon G, Ohno N, Perreau C, Borel JP, Kefalides NA (1994) The alpha 3 chain of type IV collagen prevents activation of human polymorphonuclear leukocytes. J Biol Chem 269(41):25475-25482
82. Morishita N, Kusachi S, Yamasaki S, Kondo J, Tsuji T (1996) Sequential changes in laminin and type IV collagen in the infarct zone-immunohistochemical study in rat myocardial infarction. Jpn Circ J 60(2):108-114
83. Murphy-Ullrich JE, Poczatek M (2000) Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 11(1-2):59-69 (Pubitemid 30169726)
84. Mydel P, Shipley JM, Adair-Kirk TL, Kelley DG, Broekelmann TJ, Mecham RP, Senior RM (2008) Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils. J Biol Chem 283(15):9513-9522. doi:10.1074/jbc.M706239200
85. Nagai Y, Lapiere CM, Gross J (1966) Tadpole collagenase. Preparation and purification. Biochemistry 5(10):3123-3130
86. Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P (1997) TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Embo J 16(17):5353-5362. doi:10.1093/emboj/16.17.5353 (Pubitemid 27380143)
87. Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW 2nd, Conway SJ, Aronow BJ, Robbins J, Molkentin JD (2007) Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 101(3):313-321. doi:10.1161/CIRCRESAHA.107.149047 (Pubitemid 47351119)
88. Papadopoulos DP, Moyssakis I, Makris TK, Poulakou M, Stavroulakis G, Perrea D, Votteas VE (2005) Clinical significance of matrix metalloproteinases activity in acutemyocardial infarction. Eur Cytokine Netw 16(2):152-160 (Pubitemid 46638764)
89. Patterson NL, Iyer RP, de Castro Bras LE, Li Y, Andrews TG, Aune GJ, Lange RA, Lindsey ML (2013) Using proteomics to uncover extracellular matrix interactions during cardiac remodeling. Proteomics: Clin Appl 7(7-8):516-527. doi:10.1002/prca.201200100
90. Peterson JT, Li H, Dillon L, Bryant JW (2000) Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 46(2):307-315 (Pubitemid 30204603)
91. Porter KE, Turner NA (2009) Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 123(2):255-278. doi:10.1016/j.pharmthera. 2009.05.002
92. Preissner KT, Reuning U (2011) Vitronectin in vascular context: facets of a multitalented matricellular protein. Semin Thromb Hemost 37(4):408-424. doi:10.1055/s-0031-1276590
93. Reinecke H, Minami E, Poppa V, Murry CE (2004) Evidence for fusion between cardiac and skeletal muscle cells. Circ Res 94(6):e56-e60. doi:10.1161/01.RES.0000125294.04612.81
94. Ricard-Blum S, Ballut L (2011) Matricryptins derived from collagens and proteoglycans. Front Biosci (Landmark Ed) 16:674-697
95. Romanic AM, Burns-Kurtis CL, Gout B, Berrebi-Bertrand I, Ohlstein EH (2001) Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit. Life Sci 68(7):799-814 (Pubitemid 32168010)
96. Sage EH (2001) Regulation of interactions between cells and extracellular matrix: a command performance on several stages. J Clin Invest 107(7):781-783. doi:10.1172/JCI12683
97. Sato Y, Kataoka K, Matsumori A, Sasayama S, Yamada T, Ito H, Takatsu Y (1997) Measuring serum aminoterminal type III procollagen peptide, 7S domain of type IV collagen, and cardiac troponin T in patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathy. Heart 78(5):505-508 (Pubitemid 27515114)
98. Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, Szczesna-Cordary D, Schulz R (2005) Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112(4):544-552. doi:10.1161/CIRCULATIONAHA.104.531616 (Pubitemid 41060795)
99. Schedin P, Strange R, Mitrenga T, Wolfe P, Kaeck M (2000) Fibronectin fragments induce MMP activity in mouse mammary epithelial cells: evidence for a role inmammary tissue remodeling. J Cell Sci 113(Pt 5):795-806 (Pubitemid 30168648)
100. Schoneveld AH, Hoefer I, Sluijter JP, Laman JD, de Kleijn DP, Pasterkamp G (2008) Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis 197(1):95-104. doi:10.1016/j.atherosclerosis. 2007.08.004 (Pubitemid 351273277)
101. Senior RM, Hinek A, Griffin GL, Pipoly DJ, Crouch EC, Mecham RP (1989) Neutrophils show chemotaxis to type IV collagen and its 7S domain and contain a 67 kD type IV collagen binding protein with lectin properties. Am J Respir Cell Mol Biol 1(6):479-487. doi:10.1165/ajrcmb/1.6.479
102. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G (1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 142(3):873-881 (Pubitemid 28381502)
103. Shamhart PE, Meszaros JG (2010) Non-fibrillar collagens: key mediators of post-infarction cardiac remodeling? J Mol Cell Cardiol 48(3):530-537. doi:10.1016/j.yjmcc.2009.06.017
104. Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, Saito M, Fukuda K, Nishiyama T, Kitajima S, Saga Y, Fukayama M, Sata M, Kudo A (2008) Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 205(2):295-303. doi:10.1084/jem.20071297 (Pubitemid 351281595)
105. Silzle T, Randolph GJ, Kreutz M, Kunz-Schughart LA (2004) The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer 108(2):173-180. doi:10.1002/ijc.11542 (Pubitemid 37541767)
106. Souders CA, Bowers SL, Baudino TA (2009) Cardiac fibroblast: the renaissance cell. Circ Res 105(12):1164-1176. doi:10.1161/CIRCRESAHA.109.209809
107. Squire IB, Evans J, Ng LL, Loftus IM, Thompson MM (2004) Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J Card Fail 10(4):328-333 (Pubitemid 39092685)
108. Suzuki N, Yokoyama F, Nomizu M (2005) Functional sites in the laminin alpha chains. Connect Tissue Res 46(3):142-152. doi:10.1080/03008200591008527 (Pubitemid 41283147)
109. Szadkowska I, Wlazel RN, Migala M, Bajon-Laskowska K, Szadkowski K, Zielinska M, Paradowski M, Pawlicki L (2013) The association between galectin-3 and occurrence of reinfarction early after first myocardial infarction treated invasively. Biomarkers 18(8):655-659. doi:10.3109/1354750X.2013.840801
110. Tamaoki M, Imanaka-Yoshida K, Yokoyama K, Nishioka T, Inada H, Hiroe M, Sakakura T, Yoshida T (2005) Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol 167(1):71-80. doi:10.1016/S0002-9440(10)62954-9 (Pubitemid 40884771)
111. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3(5):349-363. doi:10.1038/nrm809 (Pubitemid 34619269)
112. Trial J, Cieslik KA, Haudek SB, Duerrschmid C, Entman ML (2013) Th1/M1 conversion to th2/m2 responses in models of inflammation lacking cell death stimulates maturation of monocyte precursors to fibroblasts. Front Immunol 4:287. doi:10.3389/fimmu.2013.00287
113. Trial J, Rossen RD, Rubio J, Knowlton AA (2004) Inflammation and ischemia: macrophages activated by fibronectin fragments enhance the survival of injured cardiac myocytes. Exp Biol Med 229(6):538-545 (Pubitemid 38736323)
114. Tsai TH, Sung PH, Chang LT, Sun CK, Yeh KH, Chung SY, Chua S, Chen YL, Wu CJ, Chang HW, Ko SF, Yip HK (2012) Value and level of galectin-3 in acute myocardial infarction patients undergoing primary percutaneous coronary intervention. J Atheroscler Thromb 19(12):1073-1082
115. Turner NA, Porter KE (2013) Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis Tissue Repair 6(1):5. doi:10.1186/1755-1536- 6-5
116. van den Borne SW, Cleutjens JP, Hanemaaijer R, Creemers EE, Smits JF, Daemen MJ, Blankesteijn WM (2009) Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol 18(1):37-43. doi:10.1016/j.carpath.2007.12.012
117. Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrixmetalloproteinase gene family. Proc Natl Acad Sci U S A 87(14):5578-5582
118. Vanhoutte D, Schellings M, Pinto Y, Heymans S (2006) Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res 69(3):604-613. doi:10.1016/j.cardiores.2005. 10.002 (Pubitemid 43139724)
119. Vanhoutte D, Schellings MW, Gotte M, Swinnen M, Herias V, Wild MK, Vestweber D, Chorianopoulos E, Cortes V, Rigotti A, Stepp MA, Van de Werf F, Carmeliet P, Pinto YM, Heymans S (2007) Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction. Circulation 115(4):475-482. doi:10.1161/CIRCULATIONAHA.106.644609 (Pubitemid 46184199)
120. Verrecchia F, Chu ML, Mauviel A (2001) Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276(20):17058-17062. doi:10.1074/jbc.M100754200
121. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92(8):827-839. doi:10.1161/01.RES.0000070112.80711.3D (Pubitemid 36542523)
122. Weber KT (1997) Monitoring tissue repair and fibrosis from a distance. Circulation 96(8):2488-2492
123. Weber KT, Sun Y, Tyagi SC, Cleutjens JP (1994) Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26(3):279-292. doi:10.1006/jmcc.1994.1036 (Pubitemid 24199288)
124. Weir RA, Clements S, Steedman T, Dargie HJ, McMurray JJ, Squire IB, Ng LL (2011) Plasma TIMP-4 predicts left ventricular remodeling after acute myocardial infarction. J Card Fail 17(6):465-471. doi:10.1016/j.cardfail.2011. 02.002
125. Weir RA, Petrie CJ, Murphy CA, Clements S, Steedman T, Miller AM, McInnes IB, Squire IB, Ng LL, Dargie HJ, McMurray JJ (2013) Galectin-3 and cardiac function in survivors of acute myocardial infarction. Circ Heart Fail 6(3):492-498. doi:10.1161/CIRCHEARTFAILURE.112.000146
126. Weis SM, Zimmerman SD, Shah M, Covell JW, Omens JH, Ross J Jr, Dalton N, Jones Y, Reed CC, Iozzo RV, McCulloch AD (2005) A role for decorin in the remodeling of myocardial infarction. Matrix Biol 24(4):313-324. doi:10.1016/j.matbio.2005.05.003 (Pubitemid 40853880)
127. Westermann D, Mersmann J, Melchior A, Freudenberger T, Petrik C, Schaefer L, Lullmann-Rauch R, Lettau O, Jacoby C, Schrader J, Brand-Herrmann SM, Young MF, Schultheiss HP, Levkau B, Baba HA, Unger T, Zacharowski K, Tschope C, Fischer JW (2008) Biglycan is required for adaptive remodeling after myocardial infarction. Circulation 117(10):1269-1276. doi:10.1161/CIRCULATIONAHA.107.714147 (Pubitemid 351365659)
128. Xia Y, Dobaczewski M, Gonzalez-Quesada C, Chen W, Biernacka A, Li N, Lee DW, Frangogiannis NG (2011) Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism. Hypertension 58(5):902-911. doi:10.1161/HYPERTENSIONAHA.111.175323
129. Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML (2013) Matrix metalloproteinase-9: many shades of function in cardiovascular disease. Physiology (Bethesda) 28(6):391-403. doi:10.1152/physiol.00029.2013
130. Yamamoto K, Kusachi S, Ninomiya Y, Murakami M, Doi M, Takeda K, Shinji T, Higashi T, Koide N, Tsuji T (1998) Increase in the expression of biglycan mRNA expression co-localized closely with that of type I collagen mRNA in the infarct zone after experimentally-induced myocardial infarction in rats. J Mol Cell Cardiol 30(9):1749-1756. doi:10.1006/jmcc.1998.0737 (Pubitemid 28430188)
131. Yang RY, Rabinovich GA, Liu FT (2008) Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 10:e17. doi:10.1017/S1462399408000719
132. Zamilpa R, Ibarra J, de Castro Bras LE, Ramirez TA, Nguyen N, Halade GV, Zhang J, Dai Q, Dayah T, Chiao YA, Lowell W, Ahuja SS, D'Armiento J, Jin YF, Lindsey ML (2012) Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction. J Mol Cell Cardiol 53(5):599-608. doi:10.1016/j.yjmcc.2012.07.017
133. Zamilpa R, Lopez EF, Chiao YA, Dai Q, Escobar GP, Hakala K, Weintraub ST, Lindsey ML (2010) Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction. Proteomics 10(11):2214-2223. doi:10.1002/pmic.200900587
134. Zeisberg EM, Kalluri R (2010) Origins of cardiac fibroblasts. Circ Res 107(11):1304-1312. doi:10.1161/CIRCRESAHA.110.231910
135. Zeisberg EM, Ma Q, Juraszek AL, Moses K, Schwartz RJ, Izumo S, Pu WT (2005) Morphogenesis of the right ventricle requires myocardial expression of Gata4. J Clin Invest 115(6):1522-1531. doi:10.1172/JCI23769 (Pubitemid 40814660)
136. Zhou A, Huntington JA, Pannu NS, Carrell RW, Read RJ (2003) How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. Nat Struct Biol 10(7):541-544. doi:10.1038/nsb943 (Pubitemid 36792905)